Zymeworks to Acquire Theravance Biopharma, Inc.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Jones Trading Downgrades Theravance Biopharma (TBPH) to Hold
June 29, 2026 8:34 AM EDTJones Trading analyst Debanjana Chatterjee downgraded Theravance Biopharma (NASDAQ: TBPH) from Buy to Hold.
For an analyst ratings summary and ratings history on Theravance Biopharma click here. For more ratings news on Theravance Biopharma click here.
Shares of Theravance Biopharma closed at $17.63 yesterday.
... More